An Open-Label Pharmacokinetics and Safety Study of Talazoparib

NCT02997163 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Talazoparib

Sponsor

Pfizer

Collaborators

[object Object]